| 1. Ayijiang Taledaohan, Maer Maer TuoHan, Renbo Jia, Kai Wang, Liujia Chan, Yijiang Jia , Feng Wang*, Yuji Wang* .An RGD-Conjugated Prodrug Nanoparticle with Blood–Brain–Barrier Penetrability for Neuroprotection Against Cerebral Ischemia–Reperfusion Injury.Antioxidants.2024.13. .SCI（含SCIE） |
| 2. Anna Luzzi 1, Feng Wang 1, Shan Li 1, Michelina Iacovino 1 2, Tsui-Fen Chou 1 3.Skeletal muscle cell protein dysregulation highlights the pathogenesis mechanism of myopathy-associated p97/VCP R155H mutations.Frontiers in Neurology.2023.14.1211635.SCI |
| 3. Arpit Gupta 1, Chuqi Lu 1, Feng Wang 2, Tsui-Fen Chou 2, Shu-Ou Shan 1.An ankyrin repeat chaperone targets toxic oligomers during amyloidogenesis.Protein Science.2023.32 (8).e4728.SCI |
| 4. F Wang, S Li, WM Rosencrans, KW Cheng, GM Stott, B Mroczkowski, TF Chou.Sulforaphane is Synergistic with CB‐5083 and Inhibits Colony Formation of CB-5083-Resistant HCT116 Cells.ChemMedChem.2022.17 (11).e202200030.SCI |
| 5. S Li, F Wang, G Zhang, TF Chou.NMS-873 Leads to Dysfunctional Glycometabolism in A p97-Independent Manner in HCT116 Colon Cancer Cells.Pharmaceutics.2022.14 (4).764.SCI |
| 6. F Wang, S Li, N Houerbi, TF Chou.Temporal proteomics reveal specific cell cycle oncoprotein downregulation by p97/VCP inhibition..Cell Chemical Biology.2022.29 (3).517-529.SCI |
| 7. F Wang, S Li, KW Cheng, WM Rosencrans, TF Chou.The p97 Inhibitor UPCDC-30245 Blocks Endo-Lysosomal Degradation.Pharmaceuticals.2022.15(2).204.SCI |
| 8. F Wang, S Li, TY Wang, GA Lopez, I Antoshechkin, TF Chou.P97/VCP ATPase inhibitors can rescue p97 mutation-linked motor neuron degeneration..Brain communications.2022.4 (4).fcac176. |
| 9. .The g lobular C1q receptor is required for epidermal growth factor receptor signaling during Candida albicans infection..mBio.2021.12 (6).e02716 21. |
| 10. .Structural and Functional Analysis of Disease-Linked p97 ATPase Mutant Complexes.International journal of molecular sciences.2021.22(15).8079. |
| 11. .Neuronal VCP loss of function recapitulates FTLD-TDP pathology.Cell Reports.2021.36(3).109399. |
| 12. .Impacts of p97 on Proteome Changes in Human Cells during Coronaviral Replication.Cells.2021.10(11).2953. |
| 13. .Evaluation of artificial signal peptides for secretion of two lysosomal enzymes in CHO cells..Biochemical Journal.2021.478(12).2309. |
| 14. .A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.European Journal of Medicinal Chemistry.2021.213.113148. |
| 15. .N-myristoyltransferase-1 is necessary for lysosomal degradation and mTORC1 activation in cancer cells..Scientific reports.2020.10(1).1. |
| 16. .Enzyme Replacement Therapy for Mucopolysaccharidosis IIID using Recombinant Human α-N-Acetylglucosamine-6-Sulfatase in Neonatal Mice.Molecular Pharmaceutics.2020.18(1).214. |
| 17. .Allosteric p97 inhibitors can overcome resistance to ATP-competitive p97 inhibitors for potential anti-cancer therapy..ChemMedChem.2020.15(8).685. |
